Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol

Introduction Total mesorectal excision is the standard of care for rectal cancer, which can be performed using open, laparoscopic, robot-assisted and transanal technique. Large prospective (randomised controlled) trials comparing these techniques are lacking, do not take into account the learning cu...

Full description

Bibliographic Details
Main Authors: Maarten Postma, Roel Hompes, A.H.W. Schiphorst, Adelita Ranchor, A. Pronk, Ritch Geitenbeek, Thijs Burghgraef, David Zimmerman, Marcel Dijkgraaf, Paul Verheijen, Esther Consten, G.J.D. van Acker, T.S. Aukema, H.J. Belgers, F.H. Beverdam, J.G. Bloemen, K. Bosscha, S.O. Breukink, P.P.L.O. Coene, R.M.P.H. Crolla, P. van Duijvendijk, E.B. van Duyn, I.F. Faneyte, S.A.F. Fransen, A.A.W. van Geloven, M.F. Gerhards, W.M.U. van Grevenstein, K. Havenga, I.H.J.T. de Hingh, C. Hoff, G. Kats, J.W.A. Leijtens, M.F. Lutke Holzik, J. Melenhorst, M.M. Poelman, J.M.J. Schreinemakers, C. Sietses, A.B. Smits, I Somers, E.J. Spillenaar Bilgen, H.B.A.C. Stockmann, A.K. Talsma, P.J. Tanis, J. Tuynman, E.G.G. Verdaasdonk, F.A.R.M. Warmerdam, H.L. van Westreenen, D.D.E. Zimmerman
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/8/e057640.full
_version_ 1817995567749398528
author Maarten Postma
Roel Hompes
A.H.W. Schiphorst
Adelita Ranchor
A. Pronk
Ritch Geitenbeek
Thijs Burghgraef
David Zimmerman
Marcel Dijkgraaf
Paul Verheijen
Esther Consten
G.J.D. van Acker
T.S. Aukema
H.J. Belgers
F.H. Beverdam
J.G. Bloemen
K. Bosscha
S.O. Breukink
P.P.L.O. Coene
R.M.P.H. Crolla
P. van Duijvendijk
E.B. van Duyn
I.F. Faneyte
S.A.F. Fransen
A.A.W. van Geloven
M.F. Gerhards
W.M.U. van Grevenstein
K. Havenga
I.H.J.T. de Hingh
C. Hoff
G. Kats
J.W.A. Leijtens
M.F. Lutke Holzik
J. Melenhorst
M.M. Poelman
J.M.J. Schreinemakers
C. Sietses
A.B. Smits
I Somers
E.J. Spillenaar Bilgen
H.B.A.C. Stockmann
A.K. Talsma
P.J. Tanis
J. Tuynman
E.G.G. Verdaasdonk
F.A.R.M. Warmerdam
H.L. van Westreenen
D.D.E. Zimmerman
author_facet Maarten Postma
Roel Hompes
A.H.W. Schiphorst
Adelita Ranchor
A. Pronk
Ritch Geitenbeek
Thijs Burghgraef
David Zimmerman
Marcel Dijkgraaf
Paul Verheijen
Esther Consten
G.J.D. van Acker
T.S. Aukema
H.J. Belgers
F.H. Beverdam
J.G. Bloemen
K. Bosscha
S.O. Breukink
P.P.L.O. Coene
R.M.P.H. Crolla
P. van Duijvendijk
E.B. van Duyn
I.F. Faneyte
S.A.F. Fransen
A.A.W. van Geloven
M.F. Gerhards
W.M.U. van Grevenstein
K. Havenga
I.H.J.T. de Hingh
C. Hoff
G. Kats
J.W.A. Leijtens
M.F. Lutke Holzik
J. Melenhorst
M.M. Poelman
J.M.J. Schreinemakers
C. Sietses
A.B. Smits
I Somers
E.J. Spillenaar Bilgen
H.B.A.C. Stockmann
A.K. Talsma
P.J. Tanis
J. Tuynman
E.G.G. Verdaasdonk
F.A.R.M. Warmerdam
H.L. van Westreenen
D.D.E. Zimmerman
collection DOAJ
description Introduction Total mesorectal excision is the standard of care for rectal cancer, which can be performed using open, laparoscopic, robot-assisted and transanal technique. Large prospective (randomised controlled) trials comparing these techniques are lacking, do not take into account the learning curve and have short-term or long-term oncological results as their primary endpoint, without addressing quality of life, functional outcomes and cost-effectiveness. Comparative data with regard to these outcomes are necessary to identify the optimal minimally invasive technique and provide guidelines for clinical application.Methods and analysis This trial will be a prospective observational multicentre cohort trial, aiming to compare laparoscopic, robot-assisted and transanal total mesorectal excision in adult patients with rectal cancer performed by experienced surgeons in dedicated centres. Data collection will be performed in collaboration with the prospective Dutch ColoRectal Audit and the Prospective Dutch ColoRectal Cancer Cohort. Quality of life at 1 year postoperatively will be the primary outcome. Functional outcomes, cost-effectiveness, short-term outcomes and long-term oncological outcomes will be the secondary outcomes. In total, 1200 patients will be enrolled over a period of 2 years in 26 dedicated centres in the Netherlands. The study is registered at https://www.trialregister.nl/9734 (NL9734).Ethics and dissemination Data will be collected through collaborating parties, who already obtained approval by their medical ethical committee. Participants will be included in the trial after having signed informed consent. Results of this study will be disseminated to participating centres, patient organisations, (inter)national society meetings and peer-reviewed journals.
first_indexed 2024-04-14T02:08:03Z
format Article
id doaj.art-77bfc4094b08413a9e85b3f1bc9da01d
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-14T02:08:03Z
publishDate 2022-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-77bfc4094b08413a9e85b3f1bc9da01d2022-12-22T02:18:34ZengBMJ Publishing GroupBMJ Open2044-60552022-08-0112810.1136/bmjopen-2021-057640Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol 0Maarten Postma1Roel Hompes2A.H.W. SchiphorstAdelita Ranchor3A. Pronk4Ritch Geitenbeek5Thijs Burghgraef6David Zimmerman7Marcel Dijkgraaf8Paul Verheijen9Esther Consten10G.J.D. van AckerT.S. AukemaH.J. BelgersF.H. BeverdamJ.G. BloemenK. BosschaS.O. BreukinkP.P.L.O. CoeneR.M.P.H. CrollaP. van DuijvendijkE.B. van DuynI.F. FaneyteS.A.F. FransenA.A.W. van GelovenM.F. GerhardsW.M.U. van GrevensteinK. HavengaI.H.J.T. de HinghC. HoffG. KatsJ.W.A. LeijtensM.F. Lutke HolzikJ. MelenhorstM.M. PoelmanJ.M.J. SchreinemakersC. SietsesA.B. SmitsI SomersE.J. Spillenaar BilgenH.B.A.C. StockmannA.K. TalsmaP.J. TanisJ. TuynmanE.G.G. VerdaasdonkF.A.R.M. WarmerdamH.L. van WestreenenD.D.E. Zimmerman3International CollaborationUnit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center, Groningen, The NetherlandsSurgery, Amsterdam UMC,University of Amsterdam, Amsterdam, The Netherlands4 Department of Health Psychology, University Medical Center Groningen, Groningen, The NetherlandsIRAS-TNODepartment of Surgery, University Medical Centre, Groningen, The NetherlandsDepartment of Surgery, University Medical Centre, Groningen, The NetherlandsDepartment of Surgery, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The NetherlandsDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, UMC - Locatie AMC, Amsterdam, The NetherlandsDepartment of Surgery, Meander Medical Centre, Amersfoort, The NetherlandsDepartment of Surgery, Meander Medical Centre, Amersfoort, The NetherlandsIntroduction Total mesorectal excision is the standard of care for rectal cancer, which can be performed using open, laparoscopic, robot-assisted and transanal technique. Large prospective (randomised controlled) trials comparing these techniques are lacking, do not take into account the learning curve and have short-term or long-term oncological results as their primary endpoint, without addressing quality of life, functional outcomes and cost-effectiveness. Comparative data with regard to these outcomes are necessary to identify the optimal minimally invasive technique and provide guidelines for clinical application.Methods and analysis This trial will be a prospective observational multicentre cohort trial, aiming to compare laparoscopic, robot-assisted and transanal total mesorectal excision in adult patients with rectal cancer performed by experienced surgeons in dedicated centres. Data collection will be performed in collaboration with the prospective Dutch ColoRectal Audit and the Prospective Dutch ColoRectal Cancer Cohort. Quality of life at 1 year postoperatively will be the primary outcome. Functional outcomes, cost-effectiveness, short-term outcomes and long-term oncological outcomes will be the secondary outcomes. In total, 1200 patients will be enrolled over a period of 2 years in 26 dedicated centres in the Netherlands. The study is registered at https://www.trialregister.nl/9734 (NL9734).Ethics and dissemination Data will be collected through collaborating parties, who already obtained approval by their medical ethical committee. Participants will be included in the trial after having signed informed consent. Results of this study will be disseminated to participating centres, patient organisations, (inter)national society meetings and peer-reviewed journals.https://bmjopen.bmj.com/content/12/8/e057640.full
spellingShingle Maarten Postma
Roel Hompes
A.H.W. Schiphorst
Adelita Ranchor
A. Pronk
Ritch Geitenbeek
Thijs Burghgraef
David Zimmerman
Marcel Dijkgraaf
Paul Verheijen
Esther Consten
G.J.D. van Acker
T.S. Aukema
H.J. Belgers
F.H. Beverdam
J.G. Bloemen
K. Bosscha
S.O. Breukink
P.P.L.O. Coene
R.M.P.H. Crolla
P. van Duijvendijk
E.B. van Duyn
I.F. Faneyte
S.A.F. Fransen
A.A.W. van Geloven
M.F. Gerhards
W.M.U. van Grevenstein
K. Havenga
I.H.J.T. de Hingh
C. Hoff
G. Kats
J.W.A. Leijtens
M.F. Lutke Holzik
J. Melenhorst
M.M. Poelman
J.M.J. Schreinemakers
C. Sietses
A.B. Smits
I Somers
E.J. Spillenaar Bilgen
H.B.A.C. Stockmann
A.K. Talsma
P.J. Tanis
J. Tuynman
E.G.G. Verdaasdonk
F.A.R.M. Warmerdam
H.L. van Westreenen
D.D.E. Zimmerman
Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
BMJ Open
title Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
title_full Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
title_fullStr Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
title_full_unstemmed Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
title_short Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in ‘dedicated centres’ in the Netherlands (VANTAGE trial): a protocol
title_sort prospective multicentre observational cohort to assess quality of life functional outcomes and cost effectiveness following minimally invasive surgical techniques for rectal cancer in dedicated centres in the netherlands vantage trial a protocol
url https://bmjopen.bmj.com/content/12/8/e057640.full
work_keys_str_mv AT prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT maartenpostma prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT roelhompes prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ahwschiphorst prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT adelitaranchor prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT apronk prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ritchgeitenbeek prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT thijsburghgraef prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT davidzimmerman prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT marceldijkgraaf prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT paulverheijen prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT estherconsten prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT gjdvanacker prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT tsaukema prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT hjbelgers prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT fhbeverdam prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT jgbloemen prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT kbosscha prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT sobreukink prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT pplocoene prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT rmphcrolla prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT pvanduijvendijk prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ebvanduyn prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT iffaneyte prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT saffransen prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT aawvangeloven prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT mfgerhards prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT wmuvangrevenstein prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT khavenga prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ihjtdehingh prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT choff prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT gkats prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT jwaleijtens prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT mflutkeholzik prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT jmelenhorst prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT mmpoelman prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT jmjschreinemakers prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT csietses prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT absmits prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT isomers prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ejspillenaarbilgen prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT hbacstockmann prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT aktalsma prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT pjtanis prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT jtuynman prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT eggverdaasdonk prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT farmwarmerdam prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT hlvanwestreenen prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol
AT ddezimmerman prospectivemulticentreobservationalcohorttoassessqualityoflifefunctionaloutcomesandcosteffectivenessfollowingminimallyinvasivesurgicaltechniquesforrectalcancerindedicatedcentresinthenetherlandsvantagetrialaprotocol